Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine
- PMID: 12649384
- DOI: 10.1124/jpet.102.047050
Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine
Abstract
The psychotropic beta-carboline alkaloids, showing high affinity for 5-hydroxytryptamine, dopamine, benzodiazepine, and imidazoline receptors and the stimulation of locus coeruleus neurons, are formed endogenously from tryptophan-derived indolealkylamines through the Pictet-Spengler condensation with aldehydes in both plants and mammals. Cytochromes P450 1A1 (18.5), 1A2 (20), and 2D6 (100) catalyzed the O-demethylation of harmaline, and CYP1A1 (98.5), CYP1A2 (35), CYP2C9 (16), CYP2C19 (30), and CYP2D6 (115) catalyzed that of harmine (relative activities). The dehydrogenation/aromatization of harmaline to harmine was not carried out by aromatase (CYP19), CYP1A2, CYP2C9, CYP2D6, CYP3A4, pooled recombinant cytochromes P450, or human liver microsomes (HLMs). Kinetic parameters were calculated for the O-demethylations mediated by each isozyme and by pooled HLMs. K(cat) (min(-1)) and K(m) Awake M) values for harmaline were: CYP1A1, 10.8 and 11.8; CYP1A2, 12.3 and 13.3; CYP2C9, 5.3 and 175; CYP2C19, 10.3 and 160; and CYP2D6, 39.9 and 1.4. Values for harmine were: CYP1A1, 45.2 and 52.2; CYP1A2, 9.2 and 14.7; CYP2C9, 11.9 and 117; CYP2C19, 21.4 and 121; and CYP2D6, 29.7 and 7.4. Inhibition studies using monoclonal antibodies confirmed that CYP1A2 and CYP2D6 were the major isozymes contributing to both harmaline (20% and 50%, respectively) and harmine (20% and 30%) O-demethylations in pooled HLMs. The turnover numbers for CYP2D6 are among the highest ever reported for a CYP2D6 substrate. Finally, CYP2D6-transgenic mice were found to have increased harmaline and harmine O-demethylase activities as compared with wild-type mice. These findings suggest a role for polymorphic CYP2D6 in the pharmacology and toxicology of harmine and harmaline.
Similar articles
-
Interspecies metabolic diversity of harmaline and harmine in in vitro 11 mammalian liver microsomes.Drug Test Anal. 2017 May;9(5):754-768. doi: 10.1002/dta.2028. Epub 2016 Jul 5. Drug Test Anal. 2017. PMID: 27377954
-
Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.Biochem Pharmacol. 2010 Jul 1;80(1):122-8. doi: 10.1016/j.bcp.2010.02.020. Epub 2010 Mar 3. Biochem Pharmacol. 2010. PMID: 20206139 Free PMC article.
-
Metabolic pathways of the psychotropic-carboline alkaloids, harmaline and harmine, by liquid chromatography/mass spectrometry and NMR spectroscopy.Food Chem. 2012 Sep 15;134(2):1096-105. doi: 10.1016/j.foodchem.2012.03.024. Epub 2012 Mar 16. Food Chem. 2012. PMID: 23107733
-
Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes.Biochem Pharmacol. 1999 Mar 1;57(5):465-80. doi: 10.1016/s0006-2952(98)00268-8. Biochem Pharmacol. 1999. PMID: 9952310 Review.
-
Polymorphic cytochromes P450 and drugs used in psychiatry.Cell Mol Neurobiol. 1999 Jun;19(3):325-54. doi: 10.1023/a:1006945715127. Cell Mol Neurobiol. 1999. PMID: 10319191 Free PMC article. Review.
Cited by
-
A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach.Chem Res Toxicol. 2007 Mar;20(3):531-42. doi: 10.1021/tx600320w. Epub 2007 Feb 6. Chem Res Toxicol. 2007. PMID: 17279779 Free PMC article.
-
Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans.Pharmacogenomics J. 2005;5(3):173-82. doi: 10.1038/sj.tpj.6500305. Pharmacogenomics J. 2005. PMID: 15768052 Free PMC article.
-
Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids.Pharmacogn Rev. 2013 Jul;7(14):199-212. doi: 10.4103/0973-7847.120524. Pharmacogn Rev. 2013. PMID: 24347928 Free PMC article. Review.
-
Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.Pharmacol Rep. 2016 Jun;68(3):608-15. doi: 10.1016/j.pharep.2016.01.008. Epub 2016 Feb 5. Pharmacol Rep. 2016. PMID: 26977821 Free PMC article.
-
Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells.Eur J Neurosci. 2010 Apr;31(7):1185-93. doi: 10.1111/j.1460-9568.2010.07142.x. Epub 2010 Mar 22. Eur J Neurosci. 2010. PMID: 20345925 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous